featured
Tumor Immune Contexture Is a Determinant of Anti-CD19 CAR T-Cell Therapy Efficacy in LBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
Nat. Med. 2022 Aug 29;[EPub Ahead of Print], N Scholler, R Perbost, FL Locke, MD Jain, S Turcan, C Danan, EC Chang, SS Neelapu, DB Miklos, CA Jacobson, LJ Lekakis, Y Lin, A Ghobadi, JJ Kim, J Chou, V Plaks, Z Wang, A Xue, M Mattie, JM Rossi, A Bot, J GalonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.